NCT00935831View on ClinicalTrials.gov

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 12, 2009

Primary Completion Date

April 27, 2010

Study Completion Date

April 27, 2010

Conditions

Kidney Disease

Interventions

DRUG

GSK1278863A

50mg, 150mg

DRUG

Placebo

matching placebo

Trial Locations (1)

8011

GSK Investigational Site, Christchurch

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY